Gene transfer of two entry inhibitors protects CD4+ T cell from HIV-1 infection in humanized mice

Gene Therapy

Volumn 23, Issue 2, 2016, Pages 144-150

  Petit, N Y ^a   Baillou, C ^a   Burlion, A ^a   Dorgham, K ^a   Levacher, B ^a   Amiel, C ^a,b   Schneider, V ^b   Lemoine, F M ^a   Gorochov, G ^a,c   Marodon, G ^a  

^a SORBONNE UNIVERSITÉ   (France)

^b HÔPITAL TENON   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

LENTIVIRUS VECTOR; VIRUS FUSION INHIBITOR; C46 HIV-1 FUSION INHIBITORY PEPTIDE; CD34 ANTIGEN; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CCR5 ANTAGONIST; HYBRID PROTEIN; RANTES;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; EX VIVO STUDY; GENE EXPRESSION; GENE TRANSFER; GENETIC ENGINEERING; HEMATOPOIETIC CELL; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MOUSE; NOD SCID MOUSE; NONHUMAN; NONVIRAL GENE THERAPY; PRIORITY JOURNAL; STEM CELL; T LYMPHOCYTE; VIRUS ENTRY; VIRUS LOAD; ANIMAL; FEMALE; GENE VECTOR; GENETICS; HIV INFECTIONS; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; LENTIVIRINAE; METABOLISM; NONOBESE DIABETIC MOUSE; SCID MOUSE; TRANSPLANTATION; VIROLOGY;

ANIMALS; ANTIGENS, CD34; CCR5 RECEPTOR ANTAGONISTS; CD4-POSITIVE T-LYMPHOCYTES; CHEMOKINE CCL5; FEMALE; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HIV INFECTIONS; HIV-1; HUMANS; LENTIVIRUS; MICE; MICE, INBRED NOD; MICE, SCID; RECEPTORS, CCR5; RECOMBINANT FUSION PROTEINS; VIRUS INTERNALIZATION;

EID: 84956930907     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/gt.2015.101     Document Type: Article

References (31)

1. Martinson JJ, Chapman NH, Rees DC, Liu YT, Clegg JB. Global distribution of the CCR5 gene 32-basepair deletion. Nat Genet 1997; 16: 100-103.
2. Allers K, Hütter G, Hofmann J, Loddenkemper C, Rieger K, Thiel E et al. Evidence for the cure of HIV infection by CCR5?32/?32 stem cell transplantation. Blood 2011; 117: 2791-2799.
3. Holt N, Wang J, Kim K, Friedman G, Wang X, Taupin V et al. Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo. Nat Biotechnol 2010; 28: 839-847.
4. Didigu CA, Wilen CB, Wang J, Duong J, Secreto AJ, Danet-Desnoyers GA et al. Simultaneous zinc-finger nuclease editing of the HIV coreceptors ccr5 and cxcr4 protects CD4+ T cells from HIV-1 infection. Blood 2014; 123: 61-69.
5. Perez EE, Wang J, Miller JC, Jouvenot Y, Kim KA, Liu O et al. Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases. Nat Biotechnol 2008; 26: 808-816.
6. Tebas P, Stein D, Tang WW, Frank I, Wang SQ, Lee G et al. Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV. N Engl JMed 2014; 370: 901-910.
7. Peterson CW, Younan P, Jerome KR, Kiem H-P. Combinatorial anti-HIV gene therapy: using a multipronged approach to reach beyond HAART. Gene Ther 2013; 20: 695-702.
8. Colin P, Bénureau Y, Staropoli I, Wang Y, Gonzalez N, Alcami J et al. HIV-1 exploits CCR5 conformational heterogeneity to escape inhibition by chemokines. Proc Natl Acad Sci USA 2013; 110: 9475-9480.
9. Greenberg ML, Cammack N. Resistance to enfuvirtide, the first HIV fusion inhibitor. J Antimicrob Chemother 2004; 54: 333-340.
10. Von Laer D, Hasselmann S, Hasselmann K. Gene therapy for HIV infection: what does it need to make it work? J Gene Med 2006; 8: 658-667.
11. Doitsh G, Galloway NLK, Geng X, Yang Z, Monroe KM, Zepeda O et al. Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection. Nature 2014; 505: 509-514.
12. Heredia A, Gilliam B, DeVico A, Le N, Bamba D, Flinko R et al. CCR5 density levels on primary CD4 T cells impact the replication and Enfuvirtide susceptibility of R5 HIV-1. Aids 2007; 21: 1317-1322.
13. Anastassopoulou CG, Ketas TJ, Sanders RW, Klasse PJ, Moore JP. Effects of sequence changes in the HIV-1 gp41 fusion peptide on CCR5 inhibitor resistance. Virology 2012; 428: 86-97.
14. Petit N, Dorgham K, Levacher B, Burlion A, Gorochov G, G Marodon. Targeting both viraland host determinants of human immunodeficiency virus entry, using a new lentiviral vector coexpressing the T20 fusion inhibitor and a selective CCL5 intrakine. Hum Gene Ther Methods 2014; 25: 232-240.
15. Hartley O, Dorgham K, Perez-Bercoff D, Cerini F, Heimann A, Gaertner H et al. Human immunodeficiency virus type 1 entry inhibitors selected on living cells from a library of phage chemokines. J Virol 2003; 77: 6637-6644.
16. Schroers R, Davis CM, Wagner HJ, Chen SY. Lentiviral transduction of human T-lymphocytes with a RANTES intrakine inhibits human immunodeficiency virus type 1 infection. Gene Ther 2002; 9: 889-897.
17. Egelhofer M, Brandenburg G, Martinius H, Schult-Dietrich P, Melikyan G, Kunert R et al. Inhibition of human immunodeficiency virus type 1 entry in cells expressing gp41-derived peptides. J Virol 2004; 78: 568-575.
18. Kimpel J, Braun SE, Qiu G, Wong FE, Conolle M, Schmitz JE et al. Survival of the fittest: positive selection of CD4+ T cells expressing a membrane-bound fusion inhibitor following HIV-1 infection. PLoS One 2010; 5: e12357.
19. Burke BP, Levin BR, Zhang J, Sahakyan A, Boyer J, Carroll MV et al. Engineering cellular resistance to HIV-1 infection in vivo using a dual therapeutic lentiviral vector. Mol Ther Acids 2015; 4: e236.
20. Trobridge GD, Wu RA, Beard BC, Chiu SY, Munõz NM, von Laer D et al. Protection of stem cell-derived lymphocytes in a primate AIDS gene therapy model after in vivo selection. PLoS One 2009; 4: e7693.
21. King MA, Covassin L, Brehm MA, Racki W, Pearson T, Leif J et al. Human peripheral blood leucocyte non-obese diabetic-severe combined immunodeficiency interleukin-2 receptor gamma chain gene mouse model of xenogeneic graftversus-host-like disease and the role of host major histocompatibility complex. Clin Exp Immunol 2009; 157: 104-118.
22. Younan PM, Polacino P, Kowalski JP, Peterson CW, Maurice NJ, Williams NP et al. Positive selection of mC46-expressing CD4+ T cells and maintenance of virus specific immunity in a primate AIDS model. Blood 2013; 122: 179-187.
23. Shimizu S, Ringpis G-E, Marsden MD, Cortado RV, Wilhalme HM, Elashoff D et al. RNAi-mediated CCR5 knockdown provides HIV-1 resistance to memory T cells in humanized BLT mice. Mol Ther Nucleic Acids 2015; 4: e227.
24. Myburgh R, Ivic S, Pepper MS, Gers-Huber G, Li D, Audigé A et al. Lentivector knock-down of CCR5 in hematopoietic stem cells confers functional and persistent HIV-1 resistance in humanized mice. J Virol 2015; 89: 6761-6772.
25. Walker JE, Chen RX, McGee J, Nacey C, Pollard RB, Abedi M et al. Generation of an HIV-1-resistant immune system with CD34+ hematopoietic stem cells transduced with a triple-combination anti-HIV lentiviral vector. J Virol 2012; 86: 5719-5729.
26. De Ravin SS, Gray JT, Throm RE, Spindler J, Kearney M, Wu X et al. False-positive HIV PCR test following ex vivo lentiviral gene transfer treatment of X-linked severe combined immunodeficiency vector. Mol Ther 2014; 22: 244-245.
27. Abarrategui-Pontes C, Créneguy A, Thinard R, Fine EJ, Thepenier V, Fournier LRL et al. Codon swapping of zinc finger nucleases confers expression in primary cells and in vivo from a single lentiviral vector. Curr Gene Ther 2014; 14: 365-376.
28. DiGiusto DL, Krishnan A, Li L, Li H, Li S, Rao A et al. RNA-based gene therapy for HIV with lentiviral vector-modified CD34(+) cells in patients undergoing transplantation for AIDS-related lymphoma. Sci Transl Med 2010; 2: 36-43.
29. Podsakoff GM, Engel BC, Carbonaro DA, Choi C, Smogorzewska EM, Bauer G et al. Selective survival of peripheral blood lymphocytes in children with HIV-1 following delivery of an anti-HIV gene to bone marrow CD34+ cells. Mol Ther 2005; 12: 77-86.
30. Zufferey R, Dull T, Mandel RJ, Bukovsky A, Quiroz D, Naldini L et al. Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J Virol 1998; 98: 9873-9880.
31. Marodon G, Mouly E, Blair EJ, Frisen C, Lemoine FM, Klatzmann D. Specific transgene expression in human and mouse CD4+ cells using lentiviral vectors with regulatory sequences from the CD4 gene. Blood 2003; 101: 3416-3423.